Search "nicotinamide riboside benefits" and you meet two internets. One promises NR reverses aging, rewinds tired cells, and hands back the energy of your thirties. The other, the peer-reviewed one, is more careful, and far more interesting.
The honest version: In human trials, nicotinamide riboside (NR) does two things reliably: it raises NAD+ levels, and it is well tolerated. What it has not been shown to do is deliver the dramatic, felt results the marketing implies. NR is a well-studied NAD+ precursor, not a one-pill answer to aging.
That gap, between "raises a lab marker" and "changes how you feel in five years," is the whole story of NR. If you are in midlife and weighing an NAD+ supplement, it is also the part most worth understanding before you spend a cent. Here is what the research actually shows, benefit by benefit, with the honest limits attached.
What is nicotinamide riboside, in one paragraph?
Nicotinamide riboside is a form of vitamin B3 that your body converts into NAD+, nicotinamide adenine dinucleotide, a coenzyme every cell uses to turn food into energy and to run hundreds of metabolic reactions. You do not take NAD+ directly. You take a precursor like NR, and your cells build NAD+ from it. NR is one of the two leading NAD+ precursors on the shelf, alongside NMN, and it is among the better-studied precursors in humans. If you want the deeper chemistry, our explainer on why NAD+ matters → walks through the coenzyme itself.
Why NAD+ and precursors like NR became a focus
The popular version of this story is out of date. A 2026 study measured NAD+ in the blood of seven separate groups of people and found it did not fall with age.1 What it did do was rise when people took a precursor. Meanwhile, in older men with sarcopenia across three ethnicities, muscle NAD+ and the enzymes that produce it were measurably reduced versus age-matched healthy controls.2
So the useful question is not whether you are running a deficit, but whether you are giving your body what it uses to keep making NAD+. That is the honest reason this category exists: precursors like NR and NMN supply the raw material your cells use to support NAD+ biosynthesis. Whether topping up that raw material makes you feel younger is a further leap, and it is the part the evidence has not finished testing.
What the research on NR actually shows
NR is one of the few ingredients in this category with real human trials behind it. Here is what they found, and just as importantly, what they did not.
1. It raises NAD+ in people, and it is well tolerated. A randomized trial published in Nature Communications in 2018 gave healthy middle-aged and older adults 1,000 mg of NR per day and reported roughly a 60% increase in blood NAD+, with a side-effect profile similar to placebo over six weeks.3 That NR raises NAD+ in a living person, not just in a dish, is one of the more settled facts in this field.
The number worth remembering: in a controlled human trial, daily NR raised blood NAD+ by about 60%, and was well tolerated over six weeks.3
2. In aged muscle, it moved the marker but not the function. This is the most instructive trial of the set. In 2019, researchers gave 12 aged men 1 g of NR daily for three weeks and looked directly at muscle.4 NR raised the muscle NAD+ metabolome, a repletion marker, and lowered several circulating inflammatory markers. But it did not improve mitochondrial bioenergetics, the actual energy-producing performance of the muscle, and the muscle's transcriptomic signature pointed toward downregulation of energy-metabolism pathways. In plain terms: the supplement moved some of the biology it was supposed to move, yet the functional payoff did not show up in three weeks. That is the honest shape of NR's evidence in miniature.
Human NR trials at a glance
| Study | What it tested | What it found |
|---|---|---|
| Martens et al., 20183 | 1,000 mg/day, healthy middle-aged & older adults | ~60% rise in blood NAD+; well tolerated |
| Elhassan et al., 20194 | 1 g/day, 3 weeks, aged men (muscle) | Muscle NAD+ metabolome and some inflammatory markers shifted; muscle energy output unchanged |
So what do those benefits actually mean for you?
Here is the quotable, accurate summary: the evidence that NR raises NAD+ and is well tolerated is solid; the evidence that those increases produce specific benefits you would feel over months or years is still developing. Both halves of that sentence are true, and most marketing only tells you the first one.
This is not a reason to be cynical about the science. It is a reason to be honest about where it stands. NR clearly does the upstream thing: it feeds the NAD+ pathway. Whether that reliably translates into the energy, recovery, and healthy-aging outcomes people hope for is the question the next decade of research has to answer. A supplement can be a reasonable, evidence-informed choice without being a proven one, and NR sits exactly there.
What nicotinamide riboside will not do
This is the part most longevity brands skip, so we will say it plainly. Based on the current evidence, NR will not reverse aging, and it will not treat, cure, or prevent any disease. It will not replace sleep, movement, and decent nutrition, the unglamorous inputs that still do most of the heavy lifting. And it will not deliver guaranteed or overnight results. The trials that show NAD+ moving ran for weeks, and the meaningful question is consistency over time. If a brand promises any of those things, for NR or any precursor, treat it as a red flag, not a selling point.
NR vs NMN: does the precursor matter?
NR and NMN are the two leading NAD+ precursors, and they sit one step apart on the same pathway: NR converts to NMN, which converts to NAD+. So NMN is one step closer to NAD+, and both are among the better-studied precursors in humans. Neither is "better" in the abstract, and there is no head-to-head consumer trial crowning a winner. What matters more than the precursor name on the front is the quality of the specific product: serving size, purity, third-party testing, and an honest label. We break the two down without the hype in our NMN vs NR guide →, and if you are curious how NMN's own evidence compares, our look at what the NMN research shows → applies the same honest lens.
Where CELLSHE fits
We will be straight with you: CELLSHE does not sell NR. We focus on the other major NAD+ precursor, NMN, which sits one step closer to NAD+ on the pathway and is the form we built our routine around for women navigating midlife.
We made that choice for a reason we can show. NMN's human evidence now includes a 60-day randomized trial in 80 healthy middle-aged adults, where blood NAD+ rose at every dose tested,5 a placebo-controlled trial that measured whole-blood NAD+ at exactly our 500 mg serving,6 and a 2026 systematic review that pooled the safety data across 15 trials.7 That is the trial depth we wanted behind the molecule in the bottle.
Our NMN 500 → delivers 500 mg of high-purity β-NMN ($49 / $39 monthly) in a single daily capsule to support NAD+ biosynthesis and cellular energy production,* and the Cellular Trio → builds it into a complete daily ritual, third-party tested, with the Certificate of Analysis available on the product page or on request. If you would rather use NR, that is a perfectly credible path. We just made a different, equally honest formulation choice. Not sure where to begin? Take the free Cellular Age Check →.
Frequently asked questions
What are the main benefits of nicotinamide riboside?
In human trials, NR's clearest, best-supported effects are that it raises NAD+ levels and is well tolerated at common doses. Other potential benefits (for energy, muscle, or healthy aging over time) are still being studied and should not be treated as established.
How long does NR take to work?
NAD+ levels can rise within days to weeks of daily use in studies. Whether you personally notice anything is individual, and the honest framing is consistency over a 60-90 day window, not an overnight effect.
Is nicotinamide riboside worth taking?
That depends on your goals and budget. NR is a legitimate, well-studied NAD+ precursor, but the research supports "raises NAD+ and is well tolerated" far more strongly than any specific felt benefit. It is a reasonable evidence-informed choice, not a proven one.
Does NR have side effects?
In placebo-controlled trials, NR's side-effect profile was generally similar to placebo at doses up to 1,000 mg per day. Individual responses vary. If you are pregnant or nursing, take medication, or have a health condition, talk to your clinician first.
Is NR or NMN better for NAD+?
Neither is clearly better. They are both NAD+ precursors one step apart on the same pathway, and product quality matters more than the precursor label. See our NMN vs NR guide for the full comparison.
References
- Human whole-blood NAD+ levels do not vary with age or lifestyle interventions (2026). Nature Metabolism. PMID: 42135539. pubmed.ncbi.nlm.nih.gov/42135539
- Mitochondrial oxidative capacity and NAD+ biosynthesis are reduced in human sarcopenia across ethnicities (2019). Nature Communications. PMID: 31862890. pubmed.ncbi.nlm.nih.gov/31862890
- Martens CR, et al. (2018). Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nature Communications. PMID: 29599478. pubmed.ncbi.nlm.nih.gov/29599478
- Elhassan YS, et al. (2019). Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD+ Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures. Cell Reports. PMID: 31412242. pubmed.ncbi.nlm.nih.gov/31412242
- The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial (2023). GeroScience. PMID: 36482258. pubmed.ncbi.nlm.nih.gov/36482258
- Wang P, et al. (2023). Fingerstick blood assay maps real-world NAD+ disparity across gender and age. Aging Cell. PMID: 37641521. pubmed.ncbi.nlm.nih.gov/37641521
- Safety and Metabolism-Related Outcomes of Oral Nicotinamide Mononucleotide Supplementation in Adults: A Systematic Review and Meta-Analysis (2026). Nutrients. PMID: 42514320. pubmed.ncbi.nlm.nih.gov/42514320
